| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Addressing the childhood cancer crisis in sub-Saharan Africa
|
Lubega, Joseph
|
|
|
24 |
7 |
p. 729-732
|
article
|
| 2 |
Adenocarcinoma of lung presenting as diffuse interstitial lung disease
|
Jayakrishnan, B
|
|
|
24 |
7 |
p. e323
|
article
|
| 3 |
Adjuvant chemotherapy for locally advanced cervical cancer
|
Sari, Sezin Yuce
|
|
|
24 |
7 |
p. e289
|
article
|
| 4 |
Adjuvant chemotherapy for locally advanced cervical cancer – Authors’ reply
|
Mileshkin, Linda R
|
|
|
24 |
7 |
p. e290
|
article
|
| 5 |
Adjuvant chemotherapy in nasopharyngeal carcinoma
|
Yip, Pui Lam
|
|
|
24 |
7 |
p. 713-715
|
article
|
| 6 |
Adjuvant immune checkpoint blockade revisited
|
van Waalwijk van Doorn-Khosrovani, Sahar Barjesteh
|
|
|
24 |
7 |
p. 717-719
|
article
|
| 7 |
2023 ASCO Annual Meeting
|
Landman, Allison
|
|
|
24 |
7 |
p. 724-725
|
article
|
| 8 |
Canada to put health warnings on individual cigarettes
|
Kirby, Tony
|
|
|
24 |
7 |
p. 726
|
article
|
| 9 |
Cancer care critically affected by USA drug shortages
|
Gourd, Elizabeth
|
|
|
24 |
7 |
p. 727
|
article
|
| 10 |
Concern over cancer treatment delays caused by staffing shortages
|
Gourd, Elizabeth
|
|
|
24 |
7 |
p. 721
|
article
|
| 11 |
Concurrent chemoradiotherapy followed by adjuvant cisplatin–gemcitabine versus cisplatin–fluorouracil chemotherapy for N2–3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial
|
Liu, Li-Ting
|
|
|
24 |
7 |
p. 798-810
|
article
|
| 12 |
Correction to Lancet Oncol 2023; 24: e242
|
|
|
|
24 |
7 |
p. e291
|
article
|
| 13 |
Dispensation for access to novel anticancer agents in France
|
Levêque, Dominique
|
|
|
24 |
7 |
p. 719-720
|
article
|
| 14 |
Endoscopic surveillance in hereditary diffuse gastric cancer
|
Tankel, James
|
|
|
24 |
7 |
p. e286
|
article
|
| 15 |
Endoscopic surveillance in hereditary diffuse gastric cancer
|
Ari, Kaso
|
|
|
24 |
7 |
p. e285
|
article
|
| 16 |
Endoscopic surveillance in hereditary diffuse gastric cancer
|
di Pietro, Massimiliano
|
|
|
24 |
7 |
p. e287
|
article
|
| 17 |
Endoscopic surveillance in hereditary diffuse gastric cancer – Authors’ reply
|
Sarvestani, A Leila
|
|
|
24 |
7 |
p. e288
|
article
|
| 18 |
First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group
|
Bond, Marinde J G
|
|
|
24 |
7 |
p. 757-771
|
article
|
| 19 |
Initially unresectable colorectal liver metastases: the best therapeutic regimens
|
Imai, Katsunori
|
|
|
24 |
7 |
p. 711-713
|
article
|
| 20 |
Italy to pass law on the right to be forgotten for cancer survivors
|
Das, Manjulika
|
|
|
24 |
7 |
p. e292
|
article
|
| 21 |
Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group
|
Dimopoulos, Meletios A
|
|
|
24 |
7 |
p. e293-e311
|
article
|
| 22 |
Meeting the need for germline testing
|
The Lancet Oncology,
|
|
|
24 |
7 |
p. 709
|
article
|
| 23 |
Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study
|
Nicholson, Brian D
|
|
|
24 |
7 |
p. 733-743
|
article
|
| 24 |
Organisations in Bangladesh urge for amendment in tobacco control bill
|
Das, Manjulika
|
|
|
24 |
7 |
p. 723
|
article
|
| 25 |
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept
|
Vitale, Alessandro
|
|
|
24 |
7 |
p. e312-e322
|
article
|
| 26 |
γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial
|
Cowan, Andrew J
|
|
|
24 |
7 |
p. 811-822
|
article
|
| 27 |
γ-Secretase inhibitors plus anti-BCMA chimeric antigen receptor T cells
|
Mussetti, Alberto
|
|
|
24 |
7 |
p. 715-717
|
article
|
| 28 |
Syrian cancer patients regain treatment access in Türkiye
|
Das, Manjulika
|
|
|
24 |
7 |
p. 728
|
article
|
| 29 |
Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses from a single-arm, phase 2 study
|
Van Cutsem, Eric
|
|
|
24 |
7 |
p. 744-756
|
article
|
| 30 |
Triaging suspected cancer with a multi-cancer early detection blood test
|
Tie, Jeanne
|
|
|
24 |
7 |
p. 710-711
|
article
|
| 31 |
Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trials
|
Vale, Claire L
|
|
|
24 |
7 |
p. 783-797
|
article
|
| 32 |
World's first alcohol health labelling policy to be introduced in Ireland
|
Burki, Talha
|
|
|
24 |
7 |
p. 722
|
article
|
| 33 |
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study
|
Harding, James J
|
|
|
24 |
7 |
p. 772-782
|
article
|
Journal description